Harry H. Penner
Director/Board Member chez CELLDEX THERAPEUTICS, INC.
Fortune : 117 096 $ au 31/03/2024
Profil
Harry H.
Penner is the founder of Nascent BioSciences Inc. (founded in 2001), Marinus Pharmaceuticals, Inc. (founded in 2003), Melinta Subsidiary Corp.
(founded in 2000), New Haven Pharmaceuticals, Inc. (founded in 2008), and QCDx LLC (founded in 2017).
He holds the titles of Chairman & Chief Executive Officer at Nascent BioSciences Inc., Director at Marinus Pharmaceuticals, Inc., Director at Melinta Subsidiary Corp., Executive Chairman at New Haven Pharmaceuticals, Inc., and Chairman at QCDx LLC.
Mr. Penner was also the founder of Prevention Pharmaceuticals, Inc., Affinimark Technologies, Inc., RHEI Pharmaceuticals, Inc., RxGen, Inc., Omax Health, Inc...Mr. Penner's current job(s) included Chairman & Chief Executive Officer at Nascent BioScience LLC (since 2001) and Independent Director at Celldex Therapeutics, Inc. (since 1997).
He is also a Director at MAKScientific LLC, CaroGen Corp., Neurovail, Inc., and Aria Neurosciences, Inc.Mr. Penner's former job(s) include Vice Chairman, President & Chief Executive Officer at Neurogen Corp.
(1993-2001), Chairman at Celldex Therapeutics, Inc. (Old), Chairman at Connecticut Technology Council, Chairman at Connecticut Board of Governors for Higher Education, Co-Chairman at Connecticut United for Research Excellence, Inc., Director at AVANT Immunotherapeutics, Inc. (1997-2008), Director at Genaissance Pharmaceuticals, Inc., Lead Director at Altus Pharmaceuticals, Inc. (2006-2009), Director at Ikonisys, Inc., and Director at Connecticut Business & Industry Association.
He also served as Executive Vice President at Novo Nordisk A (1985-1993) and President & EVP-North America at Novo Nordisk North America, Inc. (1988-1993).
Mr. Penner's education history includes an undergraduate degree from the University of Virginia, a graduate degree from Fordham University, and a graduate degree from New York University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/06/2023 | 2 790 ( 0,00% ) | 117 096 $ | 31/03/2024 |
Postes actifs de Harry H. Penner
| Sociétés | Poste | Début |
|---|---|---|
| CELLDEX THERAPEUTICS, INC. | Director/Board Member | 01/01/1997 |
| Neurovail, Inc. | Director/Board Member | - |
| Omax Health, Inc. | Founder | - |
QCDx LLC
 QCDx LLC Electronic Equipment/InstrumentsElectronic Technology QCDx LLC engages in the design, manufacture, and marketing of instruments, consumables, and reagents for the detection of rare cells in the blood circulation. The company was founded by Triantafyllos Tafas and Harry H. Penner in 2017 and is headquartered in Farmington, CT. | Founder | 01/01/2017 |
| Nascent BioScience LLC | Chief Executive Officer | 01/01/2001 |
CaroGen Corp.
 CaroGen Corp. BiotechnologyHealth Technology CaroGen Corp. operates as a vaccine company. It creates and develops virus-like-vesicle based nanoparticle vaccines to address a broad range of infectious and chronic diseases. The company was founded by Bijan Almassian, John Rose, Michael Robek and Valerian Nakaar on November 16, 2012 and is headquartered in Hamden, CT. | Director/Board Member | - |
MAKScientific LLC
 MAKScientific LLC Pharmaceuticals: MajorHealth Technology MAKScientific LLC develops drugs to treat medical disorders by modulating the endocannabinoid system. The firm discovers medications for metabolic disorders, pain, addiction, and neurological diseases. The company was founded by Alexandros Makriyannis in 2004 and is headquartered in Mystic, CT. | Director/Board Member | - |
Prevention Pharmaceuticals, Inc.
 Prevention Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prevention Pharmaceuticals, Inc. manufactures pharmaceutical products. The private company is based in New Haven, CT. The company was founded by Harry H. Penner. | Founder | - |
New Haven Pharmaceuticals, Inc.
 New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Founder | 19/05/2011 |
| ░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Anciens postes connus de Harry H. Penner
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Harry H. Penner
| University of Virginia | Undergraduate Degree |
| Fordham University | Graduate Degree |
| New York University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| MARINUS PHARMACEUTICALS, INC. | Health Technology |
| CELLDEX THERAPEUTICS, INC. | Health Services |
| Entreprise privées | 25 |
|---|---|
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Health Technology |
AVANT Immunotherapeutics, Inc.
 AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | Health Technology |
Genaissance Pharmaceuticals, Inc.
 Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | Health Technology |
Celldex Therapeutics, Inc. (Old)
 Celldex Therapeutics, Inc. (Old) BiotechnologyHealth Technology Celldex Therapeutics, Inc. discovers, develops and commercialized novel immunotherapeutics. It offers treatment for cancer, infectious diseased and immune system disorders. The company was founded in May, 2003 and is headquartered in Philipsburg, NJ. | Health Technology |
Nascent BioSciences Inc.
 Nascent BioSciences Inc. Wholesale DistributorsDistribution Services Nascent BioSciences Inc. distributes liquid handling consumables for drug discovery screening applications. The company is based in Cambridge, MA. The company was founded by Harry H. Penner. Nascent BioSciences was acquired by Thermo Fisher Scientific, Inc. on January 11, 2007. | Distribution Services |
Affinimark Technologies, Inc.
 Affinimark Technologies, Inc. Medical SpecialtiesHealth Technology Affinimark Technologies, Inc. develops proprietary medical diagnostic products. Its products address lucrative market opportunities and serious unmet medical/surgical needs and its lead product, cerebrostripTM, is a strip-based diagnostic test, derived from affinimark's own cutting edge research that will quickly and cost-effectively provide a definitive determination whether the patient has suffered a cerebrospinal fluid leak as a result of surgery or trauma. The company was founded by Harry H. Penner, Jr. and Levesque Christopher in 2007 and is headquartered in New Haven, CT. | Health Technology |
Prevention Pharmaceuticals, Inc.
Prevention Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prevention Pharmaceuticals, Inc. manufactures pharmaceutical products. The private company is based in New Haven, CT. The company was founded by Harry H. Penner. | Health Technology |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Health Technology |
Ikonisys, Inc.
 Ikonisys, Inc. Medical SpecialtiesHealth Technology Ikonisys, Inc. designs and manufactures medical diagnostic products for the diagnosis of cancers. Its products include Ikoniscope Robotic Microscope that provides automated slide handling, slide scanning, real-time image capture and analysis, eliminates various factors that cause human error in testing, oncoFISH bladder that allows scanning and analysis of cells recovered from a voided urine sample. The company was founded by Pramod K. Srivastava, Petros Tsipouras, Gamil G. de Chadarevian, Michael W. Kilpatrick and Triantafyllos Tafas in 1999 and is headquartered in New Haven, CT. | Health Technology |
Connecticut Business & Industry Association
 Connecticut Business & Industry Association Miscellaneous Commercial ServicesCommercial Services Connecticut Business & Industry Association is a non-profit organization that provides commercial support services. The private company is based in Hartford, CT. Joseph F. Brennan has been the CEO of the company since 1988. | Commercial Services |
Connecticut Technology Council
 Connecticut Technology Council Miscellaneous Commercial ServicesCommercial Services The Connecticut Technology Council provides leadership, support, mentoring, and advocacy to companies across every industry and at every stage of growth in Connecticut's technology ecosystem. The non-profit company is based in Connecticut. The CEOs of the American company are Derek Slap, Matthew L. Nemerson. | Commercial Services |
| Connecticut Board of Governors for Higher Education | |
Connecticut United for Research Excellence, Inc.
 Connecticut United for Research Excellence, Inc. Miscellaneous Commercial ServicesCommercial Services Connecticut United for Research Excellence, Inc. intends to promote public understanding on the benefits of vaccines and medicines that are being offered by bioscience companies. Its members include biomedical research and educational institutions, biotechnology companies, health professionals, and healthcare systems. The company was founded on August 31, 1990 and is headquartered in New Haven, CT. | Commercial Services |
RHEI Pharmaceuticals, Inc.
 RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology RHEI Pharmaceuticals, Inc. acquires licenses, develops and commercializes therapies. The company was founded by Harry H. Penner, John W. Childs, Xin Sylvia He and Glenn A. Hopkins in 2008 and is headquartered in New Haven, CT. | Health Technology |
RxGen, Inc.
 RxGen, Inc. Miscellaneous Commercial ServicesCommercial Services RxGen, Inc. operates as a translational research company. It specializes in the fields of ophthalmology, central nervous system, cardiovascular and metabolic related disease and disorders, and have advanced discovery and development. The company was founded by Christopher M. Stanley, Steven R. Gullans and Harry H. Penner, Jr. and is headquartered in Manhattan Beach, CA. | Commercial Services |
| Novo Nordisk North America, Inc. | |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Health Technology |
MAKScientific LLC
MAKScientific LLC Pharmaceuticals: MajorHealth Technology MAKScientific LLC develops drugs to treat medical disorders by modulating the endocannabinoid system. The firm discovers medications for metabolic disorders, pain, addiction, and neurological diseases. The company was founded by Alexandros Makriyannis in 2004 and is headquartered in Mystic, CT. | Health Technology |
CaroGen Corp.
CaroGen Corp. BiotechnologyHealth Technology CaroGen Corp. operates as a vaccine company. It creates and develops virus-like-vesicle based nanoparticle vaccines to address a broad range of infectious and chronic diseases. The company was founded by Bijan Almassian, John Rose, Michael Robek and Valerian Nakaar on November 16, 2012 and is headquartered in Hamden, CT. | Health Technology |
QCDx LLC
QCDx LLC Electronic Equipment/InstrumentsElectronic Technology QCDx LLC engages in the design, manufacture, and marketing of instruments, consumables, and reagents for the detection of rare cells in the blood circulation. The company was founded by Triantafyllos Tafas and Harry H. Penner in 2017 and is headquartered in Farmington, CT. | Electronic Technology |
| Nascent BioScience LLC | |
| Omax Health, Inc. | |
| Neurovail, Inc. | |
| Aria Neurosciences, Inc. |
